Technology Venture Partners

What Technology Venture Partners does

Technology Venture Partners LLP (TVP) is a privately held, FCA-authorised venture capital firm headquartered at the Bristol and Bath Science Park in Bristol, United Kingdom. The firm was established in May 2014 when the Bristol team of YFM Equity Partners spun out as an independent fund manager and assumed management of the South West Ventures Fund, one of the UK's nine Regional Venture Capital Funds established to deploy up to £2 million of risk capital into high-growth small businesses in the South of the UK. TVP's stated remit is to provide venture capital funding together with board-level support and sector expertise to innovative technology companies seeking to scale, with a sector focus spanning enterprise software, communications and networking, electronics, advanced materials, medical technology, and healthcare IT.

TVP's core business is not the sale of technology products but the management of venture capital investments — its "products" are the portfolio companies it backs and the exits it generates. The active and historical portfolio of around a dozen companies covers point-of-care molecular diagnostics (Atlas Genetics io / binx health io, FDA-cleared for chlamydia/gonorrhea with US distribution via McKesson), radiowave breast imaging (Micrima MARIA, CE-marked), radiation detection for homeland security (Symetrica Discovery Technology, embedded in Smiths Detection RadSeeker's $143m DHS contract), enterprise software (VQ Conference Manager via Cisco, Object Matrix MatrixStore for media workflows, Dynmark/COMAPI messaging, CMS SupaTrak telematics, Covalent Cloud GRC, Eflow financial workflow, OchreSoft legal workflow), and scientific instrumentation (NanoSight nanoparticle tracking). Revenue is generated through management fees on the South West Ventures Fund and, episodically, through carried interest realised via exits: NanoSight (£15m acquisition by Spectris, 2013), Covalent Software (acquired by Ideagen, 2016), Dynmark (£11m acquisition by dotdigital, 2017), and OchreSoft (2014).

Name

Technology Venture Partners

Legal name

Technology Venture Partners LLP

Website

https://techvp.co.uk

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Technology Venture Partners is a Bristol-based, FCA-authorised venture capital firm that spun out of YFM Equity Partners in 2014 to manage the South West Ventures Fund, investing up to £2m in high-growth UK technology companies across software, diagnostics, and security.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Other Investment Pools and Funds (5259), Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Venture capital investing
• Early-stage technology funding
• Growth capital management
• Portfolio company support
• UK regional venture funds

Headquarters

HQ city

Bristol

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others

Distribution channels1 record

Marketing channels2 records

Core offering

Technology Venture Partners is an independent venture capital firm that invests equity capital in innovative high-growth technology companies located primarily in South West England and the wider UK. The firm manages the South West Ventures Fund, deploying up to £2 million of risk capital per portfolio company, while providing board-level governance, strategic guidance, and sector expertise to help scale portfolio businesses. Returns are generated through equity exits via trade sales, IPOs, or secondary transactions.

Product overview

Technology Venture Partners is a venture capital firm that invests in emerging technology companies. Their portfolio consists of twelve distinct products spanning multiple technology sectors: diagnostics (Atlas Genetics io and binx health io for point-of-care infectious disease testing, Micrima MARIA for breast imaging), security (Symetrica radiation detection technology), enterprise software (VQ Conference Manager for video conferencing, Dynmark/COMAPI for messaging, Object Matrix MatrixStore for storage, CMS SupaTrak for fleet management, Covalent Cloud for GRC, Eflow for financial services workflow, OchreSoft for legal workflow), and scientific instruments (NanoSight nanoparticle analysis). Several products represent successful exits through acquisitions (NanoSight by Spectris, Covalent by Ideagen, Dynmark by dotdigital, OchreSoft exit).

Differentiator

Problem solved

Functional benefit

Products and services

• South West Ventures Fund (Managed Fund) A Regional Venture Capital Fund managed by Technology Venture Partners that invests up to £2m of risk capital into high-growth small businesses in the South of the UK. The fund is fully invested.
• Venture Capital Investment Services Equity investment and value-add support provided to innovative high-growth technology companies, including board-level governance, strategic guidance, and sector expertise across enterprise software, communications, networking, electronics, advanced materials, medical technology, and healthcare IT.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• CiscocoreChannel Partner/ Reseller/ DistributorVQ Communications, a TVP portfolio company, became a Cisco Solutions Plus Partner. VQ Conference Manager can now be purchased through Cisco. This is a major distribution channel for VQ's video conferencing management software.
• McKessoncoreChannel Partner/ Reseller/ Distributorbinx health partnered with global healthcare leader McKesson for the national launch and distribution of the FDA-cleared binx io platform in the US.
• Smiths Detection Inc.coreTechnology or IntegrationSymetrica's Discovery Technology is at the heart of Smiths Detection RadSeeker handheld radiation detectors. Smiths Detection was awarded an IDIQ contract with maximum value of $143 million from the US Department of Homeland Security Domestic Nuclear Detection Office for this technology.
• Bespak (Consort Medical)coreOEM/ Whitelabel/ Licensing PartnerBespak, a wholly owned subsidiary of Consort Medical, is the cartridge manufacturing partner for Atlas Genetics/binx health's io system.
• Digital GarageminorImplementation/ SI/ Consulting PartnerObject Matrix partner providing implementation support for solutions including the Sky deployment.

Scale indicators1 record

Recent moves7 records

Expansion highlights5 records

Direct peers

• Parkwalk Advisors: UK growth-tech investor spun out from the IP Group, focused on university spinouts and deep-tech companies. Highly comparable as a specialist UK deep-tech/tech VC operating regionally (Oxford/Bristol).
• Maven Capital Partners: UK regional investor managing a network of regional funds (including former UK Regional Venture Capital Funds) backing SMEs. Directly comparable as a UK regional VC with similar deal size and stage profile.
• YFM Equity Partners: TVP's former parent firm; both are UK regional VCs backing early-stage technology and growth companies. YFM's Bristol office is the very team from which TVP was spun out in 2014, making the business model, ticket size and sector focus highly comparable.
• Cambridge Innovation Capital: Cambridge-based deep-tech and life-sciences investor backing growth-stage companies spun out of the Cambridge ecosystem. Comparable as a UK sector-specialist deep-tech VC.
• Albion Capital: UK growth-stage investor with VCT and fund-of-funds structures backing technology and life-sciences companies. Comparable in UK tech and life-sciences focus and SME deal scale.
• Mercia Fund Management: UK regional VC with regional funds investing in early-stage technology companies across the Midlands and North. Comparable to TVP in regional focus, ticket size (£1–5m) and tech/health/life sciences orientation.
• Foresight Williams Technology: Joint venture between Foresight Group and Williams Advanced Engineering investing in UK deep-tech and engineering businesses. Comparable in deep-tech specialism and UK regional focus.

Broad incumbents

• Octopus Ventures: One of the largest UK VCs, with significant exposure to healthtech, deep tech and B2B software. Comparable on UK tech-investing focus but operates at much larger AUM and ticket sizes than TVP.

Regional players

• Oxford Sciences Innovation: Oxford-focused deep-tech investor backing university spinouts across life sciences, health tech and physical sciences. Comparable on deep-tech thesis but operates in a different UK region.
• Midven (now part of Foresight): West Midlands regional VC (formerly the Regional Venture Capital Fund for the West Midlands) backing early-stage technology and life-sciences companies. Closely comparable as one of the UK's nine Regional Venture Capital Funds.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/technology-venture-partners-llp

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments11 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Technology Venture Partners